Skip to content
Cryptos: 559Market Cap: $2.91T 1.4%24h Vol: $140.16BDominance: BTC 58.3% ETH 10.4%
Open Tradzy

Big move · Taiwan stocks

Lin BioScience, Inc. (6696) falls 5.5% to TWD 172.00

Its third straight daily fall.

Published 5 October 2026 · Written from Tradzy's price and volume data

Close
TWD 172.00
On the day
−5.5%
Volume
0.8× average
vs 52-week high
−12.9%

Lin BioScience, Inc. closing prices

TWD 50.00TWD 100.00TWD 150.00TWD 200.00May '26Jun '26Jul '26Aug '26Sep '26Oct '26TWD 172.00

The last 90 closes up to 5 October 2026. The live chart is on the 6696 page.

What happened

Lin BioScience, Inc. (6696) closed at TWD 172.00 on 5 October 2026, down 5.5% from TWD 182.00 the session before.

It was the third lower close in a row. Over 5 sessions the price is down 12.9%, and over 20 sessions it is up 45.8%.

The close is 12.9% below the highest close of the past year (TWD 197.50 on 24 Sept 2026) and 800.5% above the lowest (TWD 19.10 on 8 Oct 2025).

Volume was close to its recent average.

Across the 14 TAIPEIEXCHANGE stocks we track, 5 closed higher and 7 closed lower that day, with a median change of −0.13%. 6696's change was −5.5%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeTWD 182.00
CloseTWD 172.00
Change on the day−5.49%
Change over 5 sessions−12.91%
Change over 20 sessions+45.76%
Volume11.17 Million
Average volume, up to 20 sessions before13.66 Million
Volume against that average0.8 times
Highest close in the past yearTWD 197.50 (24 Sept 2026)
Lowest close in the past yearTWD 19.10 (8 Oct 2025)

The full chart and history are on Lin BioScience, Inc. (6696). More from this market: TAIPEIEXCHANGE news today.

More TAIPEIEXCHANGE moves on 5 October 2026

Want a plan for 6696? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.